Parp1
M. musculus
poly (ADP-ribose) polymerase family, member 1
What the model saw
Gene: Parp1 Organism: Mus musculus Known functions: poly (ADP-ribose) polymerase family, member 1. poly [ADP-ribose] polymerase 1. DNA binding. NAD DNA ADP-ribosyltransferase activity. NAD binding. NAD+ poly-ADP-ribosyltransferase activity. NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity. NAD+-histone H2BS6 serine ADP-ribosyltransferase activity. NAD+-histone H3S10 serine ADP-ribosyltransferase activity. NAD+-protein mono-ADP-ribosyltransferase activity. NAD+-protein-aspartate ADP-ribosyltransferase activity. NAD+-protein-glutamate ADP-ribosyltransferase activity. NAD+-protein-histidine ADP-ribosyltransferase activity. NAD+-protein-serine ADP-ribosyltransferase activity. NAD+-protein-tyrosine ADP-ribosyltransferase activity. R-SMAD binding. RNA polymerase II-specific DNA-binding transcription factor binding. chromatin binding. damaged DNA binding. enzyme activator activity. enzyme binding. histone deacetylase binding. identical protein binding. non-sequence-specific DNA binding, bending. nuclear estrogen receptor binding. nucleosome binding. protein binding. protein homodimerization activity. protein kinase binding. single-strand break-containing DNA binding. transcription regulator activator activity. ubiquitin protein ligase binding. zinc ion binding.
View unredacted entry
poly (ADP-ribose) polymerase family, member 1. poly [ADP-ribose] polymerase 1. DNA binding. NAD DNA ADP-ribosyltransferase activity. NAD binding. NAD+ poly-ADP-ribosyltransferase activity. NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity. NAD+-histone H2BS6 serine ADP-ribosyltransferase activity. NAD+-histone H3S10 serine ADP-ribosyltransferase activity. NAD+-protein mono-ADP-ribosyltransferase activity. NAD+-protein-aspartate ADP-ribosyltransferase activity. NAD+-protein-glutamate ADP-ribosyltransferase activity. NAD+-protein-histidine ADP-ribosyltransferase activity. NAD+-protein-serine ADP-ribosyltransferase activity. NAD+-protein-tyrosine ADP-ribosyltransferase activity. R-SMAD binding. RNA polymerase II-specific DNA-binding transcription factor binding. chromatin binding. damaged DNA binding. enzyme activator activity. enzyme binding. histone deacetylase binding. identical protein binding. non-sequence-specific DNA binding, bending. nuclear estrogen receptor binding. nucleosome binding. protein binding. protein homodimerization activity. protein kinase binding. single-strand break-containing DNA binding. transcription regulator activator activity. ubiquitin protein ligase binding. zinc ion binding.
Solver output
PARP1 is the primary sensor of DNA single- and double-strand breaks, consuming NAD+ to synthesize poly(ADP-ribose) chains that recruit DNA repair machinery. While this DNA repair function is ostensibly protective, hyperactivation of PARP1 in response to accumulated DNA damage massively depletes cellular NAD+ pools, which in turn suppresses SIRT1/sirtuins and impairs mitochondrial function and metabolic homeostasis — a well-documented pro-aging axis. Parp1 knockout mice show extended healthspan and lifespan in some studies, consistent with the idea that chronic PARP1 overactivation accelerates NAD+ depletion and aging. Additionally, PARP1-mediated NAD+ consumption competes directly with NAD+-dependent longevity pathways (sirtuins, NAMPT), and its chromatin-remodeling and transcriptional co-activator roles can promote inflammatory gene expression. The net effect of Parp1's normal function — particularly its NAD+-consuming ADP-ribosyltransferase activity — is therefore anti-longevity through NAD+ depletion and downstream sirtuin suppression.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted anti_longevity but the ground truth is pro_longevity. The model's reasoning is internally coherent but factually incorrect in its conclusion. The model claims "Parp1 knockout mice show extended healthspan and lifespan in some studies," which is the opposite of what GenAge records — the gene is classified as pro_longevity, meaning its presence (not absence) promotes longevity. The model's mechanistic framing around NAD+ depletion and sirtuin suppression is a real biological phenomenon, but the model incorrectly weighted this as the dominant effect. The pro_longevity classification likely reflects PARP1's critical role in DNA repair and genomic stability maintenance, which is protective against cancer and age-related genomic instability. The model's confidence of 0.72 in the wrong direction is a notable failure. The reasoning quality is poor because it misrepresents the experimental literature on Parp1 knockout mice to support an incorrect conclusion.
Raw API responses
solver
{
"reasoning": "PARP1 is the primary sensor of DNA single- and double-strand breaks, consuming NAD+ to synthesize poly(ADP-ribose) chains that recruit DNA repair machinery. While this DNA repair function is ostensibly protective, hyperactivation of PARP1 in response to accumulated DNA damage massively depletes cellular NAD+ pools, which in turn suppresses SIRT1/sirtuins and impairs mitochondrial function and metabolic homeostasis — a well-documented pro-aging axis. Parp1 knockout mice show extended healthspan and lifespan in some studies, consistent with the idea that chronic PARP1 overactivation accelerates NAD+ depletion and aging. Additionally, PARP1-mediated NAD+ consumption competes directly with NAD+-dependent longevity pathways (sirtuins, NAMPT), and its chromatin-remodeling and transcriptional co-activator roles can promote inflammatory gene expression. The net effect of Parp1's normal function — particularly its NAD+-consuming ADP-ribosyltransferase activity — is therefore anti-longevity through NAD+ depletion and downstream sirtuin suppression.",
"confidence": 0.72,
"key_pathways": [
"NAD+ consumption and sirtuin suppression",
"DNA damage response and single-strand break repair",
"Chromatin remodeling and NF-κB-mediated inflammatory signaling"
],
"mechanism_class": "genomic_instability",
"longevity_influence": "anti_longevity"
}advisor
{
"notes": "The model predicted anti_longevity but the ground truth is pro_longevity. The model's reasoning is internally coherent but factually incorrect in its conclusion. The model claims \"Parp1 knockout mice show extended healthspan and lifespan in some studies,\" which is the opposite of what GenAge records — the gene is classified as pro_longevity, meaning its presence (not absence) promotes longevity. The model's mechanistic framing around NAD+ depletion and sirtuin suppression is a real biological phenomenon, but the model incorrectly weighted this as the dominant effect. The pro_longevity classification likely reflects PARP1's critical role in DNA repair and genomic stability maintenance, which is protective against cancer and age-related genomic instability. The model's confidence of 0.72 in the wrong direction is a notable failure. The reasoning quality is poor because it misrepresents the experimental literature on Parp1 knockout mice to support an incorrect conclusion.",
"failure_mode": "confident_wrong",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": true
}